CENTER ID: | TogoA.18503.b |
ORGANISM: | Toxoplasma gondii ME49 |
ASSOCIATED DISEASE: | Toxoplasmosis |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TogoA.18503.b.B3.GE35413 | cytoplasmic domain 2 | 134 | 313 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
TogoA.18503.b.B3.PS38311 | cytoplasmic domain 2 | 134 | 313 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | ToxoDB:TGME49_218880 |
RefSeq: | XP_002370662.1 |
UniProt: | B6KS39 |
HARVESTED ON: | 5/16/2012 |
SEQUENCED ON: | 5/15/2012 |
EXPECTED MW: | 21kDa |
OBSERVED MW: | 21kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | pass with incomplete coverage |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 94 |
PURIFICATION DATe: | 6/11/2012 |
CONCENTRATION: | 13.12mg/ml |
OBSERVED MW: | 24kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | SEC Buffer: 20mM HEPES, 300mM NaCl, 5% glycerol, 1mM TCEP, pH7.0 |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | 2 |
VIAL VOLUME: | 110µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 94 |